Background: Venous thromboembolism (VTE) is a serious and potentially fatal complication
after surgery. Operations for malignancy in the upper abdomen are traditionally regarded as …

Aims The incidence of venous thromboembolism (VTE) following major abdominal cancer
surgery is reduced by extended post-operative VTE prophylaxis using low molecular weight …

Background Guidelines recommend extended venous thromboembolism (VTE) prophylaxis
for high‐risk populations undergoing major abdominal cancer operations. Few studies have …

Background Postoperative venous thromboembolism (VTE) is a significant source of
morbidity and mortality in cancer patients undergoing major abdominopelvic surgery. Many …

Background Cancer patients undergoing major abdominal or pelvic surgery are at
considerable risk of venous thromboembolism (VTE). The genesis of thromboses in …

Aim NICE guidance currently recommends extending venous thromboembolism (VTE)
prophylaxis to 28 days for patients who have undergone major cancer surgery in the …

Background Patients undergoing major abdominal surgery are at high risk for developing
venous thromboembolism in the post-operative period. Current evidence-based guidelines …

Background: The efficacy of low-molecular-weight heparin (LMWH) in preventing venous
thromboembolism (VTE) after surgery for colorectal cancer is well documented, but the …

AIMS: To review the epidemiology and pathogenesis of venous thromboembolism (VTE) in
surgical cancer patients, in addition to the use of thromboprophylaxis in major abdominal …

Introduction Patients undergoing surgery for colorectal cancer are at high risk of post‐
operative venous thromboembolism (VTE). Thromboprophylaxis has been shown to have …